Tag: DCGI
Zydus Applies to the DCGI for EUA to Launch ZyCoV-D
AHMEDABAD:Zydus Cadila today announced that the company has applied for Emergency Use Authorization (EUA) to.
Glenmark Launch Remogliflozin + Vildagliptin Fixed Dose Combination for Type 2 Diabetes
KOCHI:Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination.
BDR Receives DCGI Approval for Favipiravir to Treat COVID-19
MUMBAI: BDR Pharmaceuticals –today announced the launch of Favipiravir for the treatment of COVID-19 patients.
Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir
KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials.